Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Antivenom PolongaTAb - Protherics

Drug Profile

Antivenom PolongaTAb - Protherics

Alternative Names: PolongaTAb; Russell's viper antivenom PolongaTAb - Protherics

Latest Information Update: 23 Nov 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Protherics
  • Developer Symbion Health
  • Class Antibodies; Antivenins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Snake venom poisoning

Most Recent Events

  • 12 Jan 2006 Mayne Group is now called Symbion Health
  • 18 Oct 1999 Therapeutic Antibodies has merged with Proteus International to form Protherics
  • 27 Jul 1999 Preregistration for Snake venom poisoning in South-East Asia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top